179 related articles for article (PubMed ID: 21309258)
1. Endometrioid carcinoma of the endometrium: pathologic and molecular features.
Azueta A; Gatius S; Matias-Guiu X
Semin Diagn Pathol; 2010 Nov; 27(4):226-40. PubMed ID: 21309258
[TBL] [Abstract][Full Text] [Related]
2. Endometrioid carcinoma of the uterine corpus: a review of its pathology with emphasis on recent advances and problematic aspects.
Clement PB; Young RH
Adv Anat Pathol; 2002 May; 9(3):145-84. PubMed ID: 11981113
[TBL] [Abstract][Full Text] [Related]
3. Endometrial carcinomas: a review emphasizing overlapping and distinctive morphological and immunohistochemical features.
Bartosch C; Manuel Lopes J; Oliva E
Adv Anat Pathol; 2011 Nov; 18(6):415-37. PubMed ID: 21993268
[TBL] [Abstract][Full Text] [Related]
4. Molecular profiles of benign and (pre)malignant endometrial lesions.
van der Putten LJM; van Hoof R; Tops BBJ; Snijders MPLM; van den Berg-van Erp SH; van der Wurff AAM; Bulten J; Pijnenborg JMA; Massuger LFAG
Carcinogenesis; 2017 Mar; 38(3):329-335. PubMed ID: 28203752
[TBL] [Abstract][Full Text] [Related]
5. Laminin C1 expression by uterine carcinoma cells is associated with tumor progression.
Kashima H; Wu RC; Wang Y; Sinno AK; Miyamoto T; Shiozawa T; Wang TL; Fader AN; Shih IeM
Gynecol Oncol; 2015 Nov; 139(2):338-44. PubMed ID: 26343160
[TBL] [Abstract][Full Text] [Related]
6. beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas.
Moreno-Bueno G; Gamallo C; Pérez-Gallego L; de Mora JC; Suárez A; Palacios J
Diagn Mol Pathol; 2001 Jun; 10(2):116-22. PubMed ID: 11385321
[TBL] [Abstract][Full Text] [Related]
7. Pathologic Findings in Prophylactic and Nonprophylactic Hysterectomy Specimens of Patients With Lynch Syndrome.
Bartosch C; Pires-Luís AS; Meireles C; Baptista M; Gouveia A; Pinto C; Shannon KM; Jerónimo C; Teixeira MR; Lopes JM; Oliva E
Am J Surg Pathol; 2016 Sep; 40(9):1177-91. PubMed ID: 27340747
[TBL] [Abstract][Full Text] [Related]
8. Pathologic features of endometrial carcinoma associated with HNPCC: a comparison with sporadic endometrial carcinoma.
Broaddus RR; Lynch HT; Chen LM; Daniels MS; Conrad P; Munsell MF; White KG; Luthra R; Lu KH
Cancer; 2006 Jan; 106(1):87-94. PubMed ID: 16323174
[TBL] [Abstract][Full Text] [Related]
9. PIK3CA mutations in the kinase domain (exon 20) of uterine endometrial adenocarcinomas are associated with adverse prognostic parameters.
Catasus L; Gallardo A; Cuatrecasas M; Prat J
Mod Pathol; 2008 Feb; 21(2):131-9. PubMed ID: 18084252
[TBL] [Abstract][Full Text] [Related]
10. Dedifferentiated carcinoma with clear cell carcinoma of the endometrium: A case report.
Lee SE; Park HY; Shim SH; Kim WY
Pathol Int; 2017 Sep; 67(9):472-476. PubMed ID: 28667682
[TBL] [Abstract][Full Text] [Related]
11. Microsatellite instability in endometrioid type endometrial adenocarcinoma is associated with poor prognostic indicators.
An HJ; Kim KI; Kim JY; Shim JY; Kang H; Kim TH; Kim JK; Jeong JK; Lee SY; Kim SJ
Am J Surg Pathol; 2007 Jun; 31(6):846-53. PubMed ID: 17527071
[TBL] [Abstract][Full Text] [Related]
12. Mixed endometrial carcinomas with a "low-grade serous"-like component: a clinicopathologic, immunohistochemical, and molecular genetic study.
Espinosa I; D'Angelo E; Corominas M; Gonzalez A; Prat J
Hum Pathol; 2018 Jan; 71():65-73. PubMed ID: 29079180
[TBL] [Abstract][Full Text] [Related]
13. Ovarian and endometrial endometrioid adenocarcinomas have distinct profiles of microsatellite instability, PTEN expression, and ARID1A expression.
Huang HN; Lin MC; Tseng LH; Chiang YC; Lin LI; Lin YF; Huang HY; Kuo KT
Histopathology; 2015 Mar; 66(4):517-28. PubMed ID: 25195947
[TBL] [Abstract][Full Text] [Related]
14. How to approach the many faces of endometrioid carcinoma.
Malpica A
Mod Pathol; 2016 Jan; 29 Suppl 1():S29-44. PubMed ID: 26715172
[TBL] [Abstract][Full Text] [Related]
15. Endometrial endometrioid adenocarcinoma with a deceptive pattern of spread to the uterine cervix: a manifestation of stage IIb endometrial carcinoma liable to be misinterpreted as an independent carcinoma or a benign lesion.
Tambouret R; Clement PB; Young RH
Am J Surg Pathol; 2003 Aug; 27(8):1080-8. PubMed ID: 12883240
[TBL] [Abstract][Full Text] [Related]
16. Endometrioid endometrial carcinoma with atrophic endometrium and poor prognosis.
Geels YP; Pijnenborg JM; van den Berg-van Erp SH; Bulten J; Visscher DW; Dowdy SC; Massuger LF
Obstet Gynecol; 2012 Nov; 120(5):1124-31. PubMed ID: 23090531
[TBL] [Abstract][Full Text] [Related]
17. POLE exonuclease domain mutation predicts long progression-free survival in grade 3 endometrioid carcinoma of the endometrium.
Meng B; Hoang LN; McIntyre JB; Duggan MA; Nelson GS; Lee CH; Köbel M
Gynecol Oncol; 2014 Jul; 134(1):15-9. PubMed ID: 24844595
[TBL] [Abstract][Full Text] [Related]
18. Unusual epithelial and stromal changes in myoinvasive endometrioid adenocarcinoma: a study of their frequency, associated diagnostic problems, and prognostic significance.
Murray SK; Young RH; Scully RE
Int J Gynecol Pathol; 2003 Oct; 22(4):324-33. PubMed ID: 14501811
[TBL] [Abstract][Full Text] [Related]
19. [MELF pattern in myometrial infiltration in endometrioid adenocarcinoma of the endometrium. A retrospective study of 70 cases].
Tresserra F; Pascual MÁ; Arenas M; Blancafort C; Martínez-Lanao MÁ; Rodríguez I; Fábregas R
Rev Esp Patol; 2018; 51(2):77-83. PubMed ID: 29602378
[TBL] [Abstract][Full Text] [Related]
20. [Endometrial carcinoma and precursor lesions].
Djordjević B; Stanojević Z
Srp Arh Celok Lek; 2007; 135(3-4):230-4. PubMed ID: 17642468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
